Improved Ovarian Reserve and Gonadotropin Levels in a Young Woman Following Cyclofert- Female® Supplementation: A Case Report
Abstract
Background: Diminished ovarian reserve (DOR) is a common condition associated with accelerated
loss of ovarian function and impaired fertility. In recent years, various nutraceuticals have been studied
for their potential to support ovarian function and female reproductive health. One such formulation
is Cyclofert-Female®, which contains pycnogenol from maritime pine tree, acetyl-carnitine, diosgenin
from yam root, coenzyme Q10, glycyrrhizin from licorice root, zinc, vitamins B6, B9, B12 and E,
selenium and omega-3 fatty acids.
Case Summary: We present the case of a 34-year-old woman who sought a gynaecological consultation
due to concerns about her fertility. A baseline assessment revealed low anti-Mullerian hormone (AMH)
levels of 0.73 ng/mL, as well as elevated follicle-stimulating hormone (FSH) and luteinizing hormone
(LH) levels, which are consistent with DOR. The patient was prescribed Cyclofert-Female® for five
months. Following supplementation, a repeat hormonal assessment revealed an increase in AMH to
1.34 ng/mL, along with decreases in FSH and LH.
Conclusion: This case highlights the positive effects of Cyclofert-Female® on ovarian reserve and
gonadotropin regulation after five months of supplementation in a woman with DOR. While these
findings are encouraging, further studies and randomized controlled trials are required to confirm the
efficacy of this intervention for managing DOR.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.